4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-272572
Chief Development Officer sold 20,000 shares at an average $75.36 ($1,507,122)
- Chief Development Officer acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Guyer William · Chief Development Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $21.65 | $433,000 | 25,287 | D |
| 2025-11-05 | Sale : show line 2 in the form 10b5-1 | −6,536 | $74.75 | $488,559 | 18,751 | D |
| 2025-11-05 | Sale : show line 3 in the form 10b5-1 | −13,164 | $75.64 | $995,679 | 5,587 | D |
| 2025-11-05 | Sale : show line 4 in the form 10b5-1 | −300 | $76.28 | $22,884 | 5,287 | D |
| Open-market sales · 20,000 sh · avg $75.36 · $1,507,122 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-05 | Exercise or conversion : show line 5 in the form 10b5-1 Stock option (right to buy) | −20,000 | 290,000 | D |
Loading xslF345X05/ownership.xml…